Cohort expansion from the phase 1 JEWEL-101 study investigating the tissue factor-targeting antibody-drug conjugate XB002 in patients with advanced solid tumors: Pancreatic and esophageal cancer cohorts.

Bibliographic Details
Title:	Cohort expansion from the phase 1 JEWEL-101 study investigating the tissue factor-targeting antibody-drug conjugate XB002 in patients with advanced solid tumors: Pancreatic and esophageal cancer cohorts.
Authors:	Ulahannan, Susanna Varkey, Johnson, Melissa Lynne, Weiss, Mia C., Vandross, Andrae L., Vidal-Cardenas, Sofia Luz, Syed, Mustafa, Tolcher, Anthony W.
Source:	Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, pTPS421-TPS421, 185p
Database:	Supplemental Index

More Details
ISSN:	0732183X
DOI:	10.1200/JCO.2024.42.3_suppl.TPS421
Published in:	Journal of Clinical Oncology
Language:	English